Novartis posts positive phase III ALIGN data for Vanrafia in IgAN, showing slower kidney decline as it eyes full approval in 2026.

In this analysis of patients with myeloperoxidase-ANCA-positive AAV, all urinary complement C3 fragment levels were elevated significantly compared with healthy controls (P <.01 for all).

FROM land rows to family feuds, Justice Minister Delroy Chuck says unresolved community conflicts are feeding the nation’s ...

New data challenge common beliefs about antihistamines, corticosteroids, and vaccines in chronic urticaria, with practical ...

He calmly acknowledged that it’s now more difficult for Russia to advance its foreign policy goals due to the US’ renewed attempt to dominate the global ...

By Bernard Place EVEN if Jersey succeeds in easing pressure at the margins and restoring a first step into independent living ...

Guggenheim Securities Emerging Outlook: Biotech Summit 2026 February 12, 2026 9:30 AM ESTCompany ParticipantsJohn Butler ...

Researchers are exploring a new generation of biochemical markers that may help clinicians detect myocardial contusion. A frequently overlooked form of heart injury caused by blunt chest trauma, ...

Redevelopment firms like PREFER Access operate in a specialized segment of the market centered on acquisition, renovation, ...

Under the agreement, SanegeneBio has granted Genentech exclusive worldwide rights to develop and commercialize the undisclosed program.

Today’s gold prices see the precious metal move up from yesterday. Here are today’s gold futures prices and a quick snapshot of where gold was yesterday, as well as overall trends: Gold futures open ...